在多区域临床试验 (MRCT) 中数据聚合策略的基本考虑
Jiali Song1, Chen Ji2, Meng Chen3
1Department of Biostatistics, School of Public Health, Peking University, Beijing, China.
本研究解决了中国多区域临床试验 (MRCT) 的挑战,重点关注全球药物开发的策略,效果修饰剂和统计分析. 它为协调中国和东亚的MRCT实践提供了见解.
科学领域:
- 临床药理学 临床药理学
- 监管科学 监管科学
- 生物统计学 生物统计学
背景情况:
- 中国国家医疗药品管理局正在采用ICH E17指南,用于多区域临床试验 (MRCT).
- 中国和东亚的MRCT的执行和进行面临着关于聚合,效果修饰器和统计分析的模两可.
- 与全球试验标准的调整为区域药物开发带来了挑战.
研究的目的:
- 在中国背景下探索规划和开展MRCT的标准.
- 解决聚合策略,效果调整因子 (EMs) 的识别,统计分析和样本大小分配的模糊性.
- 为国内和国际MRCT实践的改进提供见解.
主要方法:
- 确定内在和外在因素作为潜在的效果修饰剂 (EMs),影响特定人群中的药物疗效.
- 实施区域聚合策略,评估东亚地区人口差异,当没有确定EM时.
- 使用统计模型来估计药物对聚合群体的影响.
主要成果:
- 定义了为MRCTs在中国人群中确定效果修饰剂的标准.
- 概述了区域聚合和统计分析的策略,在没有确定EMS的情况下.
- 澄清了东亚MRCT的样本大小分配考虑因素.
结论:
- 这篇论文详细介绍了中国的MRCT实践,解决了审判执行的关键挑战.
- 为协调国内和国际MRCT提供实用见解.
- 旨在改善该地区未来的多区域临床试验的规划和进行.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
相关概念视频
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Analysis of Population Pharmacokinetic Data
Clinical Trials: Overview
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Sampling Plans
Random sampling is a method where each member of the population has an equal chance of being selected for the sample. It involves selecting individuals randomly, often using random number generators or lottery-type methods. For example, when analyzing the properties of a...
